Also trades as: 4565.T (JPX) · $vol 7M
SOLTF OTC
Nxera Pharma Co., Ltd.
1W: -6.3%
1M: +56.1%
3M: +22.8%
YTD: +42.7%
1Y: +22.2%
3Y: -47.9%
5Y: -41.0%
$7.82
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$134.9B
-11.0% ▼
5Y CAGR: +12.0%
Total Liabilities
$73.9B
-11.0% ▼
5Y CAGR: +25.1%
Shareholders Equity
$61.1B
-10.9% ▼
5Y CAGR: +3.1%
Cash & Investments
$20.4B
-43.7% ▼
5Y CAGR: -12.6%
Total Debt
$60.9B
-10.3% ▼
5Y CAGR: +29.7%
Net Debt
$40.6B
+13.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $60.1B | $66.6B | $49.1B | $32.3B | $20.4B |
| Short-Term Investments | $86M | $0 | $0 | $3.9B | $0 |
| Cash & ST Investments | $60.2B | $66.6B | $49.1B | $36.2B | $20.4B |
| Net Receivables | $2.1B | $2.5B | $5.1B | $6.7B | $10.5B |
| Inventory | -$33M | $32M | $2.9B | $8.8B | $11.3B |
| Other Current Assets | $142M | $253M | $7.3B | $6.1B | $2.3B |
| Total Current Assets | $62.8B | $69.9B | $65.1B | $57.9B | $44.5B |
| Property, Plant & Equip. | $3.8B | $3.8B | $7.9B | $7.5B | $7.5B |
| Goodwill & Intangibles | $24.2B | $23.9B | $76.9B | $77.6B | $75.1B |
| Long-Term Investments | $6.0B | $1.7B | $3.3B | $583M | $2.9B |
| Other Non-Current Assets | $102M | -$742M | $42M | $4.0B | $39M |
| Total Non-Current Assets | $34.2B | $29.5B | $92.1B | $93.6B | $90.4B |
| Total Assets | $97.0B | $99.4B | $157.2B | $151.5B | $134.9B |
| — Liabilities — | |||||
| Accounts Payable | $1.2B | $1.6B | $4.2B | $4.1B | $7.5B |
| Short-Term Debt | $0 | -$296M | $5.9B | $5.8B | $6.7B |
| Deferred Revenue | $279M | $296M | $1.4B | $0 | $0 |
| Other Current Liabilities | $5.0B | $1.9B | $4.8B | $4.6B | $3.1B |
| Total Current Liabilities | $7.2B | $4.1B | $17.2B | $15.6B | $17.5B |
| Long-Term Debt | $27.4B | $28.0B | $63.2B | $57.7B | $50.7B |
| Other Non-Current Liab. | $0 | $0 | $4.5B | $4.3B | $2.1B |
| Total Non-Current Liabilities | $32.3B | $37.4B | $73.2B | $67.3B | $56.3B |
| Total Liabilities | $39.5B | $41.5B | $90.4B | $83.0B | $73.9B |
| — Equity — | |||||
| Common Stock | $41.0B | $41.3B | $46.8B | $47.2B | $47.5B |
| Retained Earnings | -$9.8B | -$8.9B | -$16.1B | -$20.9B | -$17.6B |
| Accumulated OCI | -$2.9B | -$4.0B | $2.1B | $7.2B | $9.0B |
| Total Stockholders Equity | $57.5B | $57.9B | $66.8B | $68.5B | $61.1B |
| Total Liabilities & Equity | $97.0B | $99.4B | $157.2B | $151.5B | $134.9B |
| — Key Metrics — | |||||
| Total Debt | $29.3B | $29.7B | $74.0B | $67.9B | $60.9B |
| Net Debt | -$30.8B | -$36.8B | $24.9B | $35.6B | $40.6B |
| Total Investments | $6.0B | $1.7B | $3.3B | $4.5B | $2.9B |